Another COVID-19 vaccine developed in the US

WAR ZONE
0


In the United States, the number of people affected by coronavirus and casualties is what American experts are urging.

According to a foreign news agency, the US multinational company Johnson & Johnson is working on the Corona virus vaccine.

American company Johnson & Johnson will conduct a humanitarian trial of its vaccine in September this year.

  Until next year, its first shipment will be provided for use in an emergency.

The Johnson & Johnson Company has been working on this vaccine since January of this year, with $ 1 billion allocated for further research and preparation of the vaccine.

The company has partnered this vaccine with the Biomedical Advance Research and Development Authority and Health Department of the United States.

Johnson & Johnson and the Biomedical Advance Research and Development Authority have also allocated $ 1 billion for vaccine research, manufacture and clinical testing.

The company's CEO, Avilux Groski, says the world is in crisis right now and we're taking the plunge in vaccinating this deadly virus.

According to him, if the vaccine is approved, Johnson & Johnson will also provide funding to make the vaccine larger.

It is clear that the number of people affected by Cod 19 in the United States is the highest in the United States. However, 5,507 people have been cured.

Post a Comment

0Comments
Post a Comment (0)